  
|
|
 |  |  |  |  |  |  |
|
Rheumatoid Arthritis
|
|
|
Adalimumab therapy was associated with a significant decrease in sperm count in a 35-year-old man who had taken the biologic for 3 years as treatment for ankylosing spondylitis, according to a case report presented in the March issue of Annals of the Rheumatic Diseases. Anti-tumor necrosis factor... »
TNF Inhibitors Don't Boost Zoster Risk
SNOWMASS, COLO. – The risk of herpes zoster isn’t raised in rheumatoid arthritis patients who are on a tumor necrosis factor inhibitor, compared with those on nonbiologic disease-modifying antirheumatic drugs, according to a preliminary analysis from by far the largest study to examine the... »
New Insights Gained Into Biologics' Infection Risk
SNOWMASS, COLO. – A recent, much-ballyhooed, large, observational U.S. study that revised downward the risk of serious infections posed by tumor necrosis factor–alpha inhibitor therapy may have rendered false comfort to prescribing physicians. The findings of the U.S. multicenter Safety... »
Adalimumab therapy was associated with a significant decrease in sperm count in a 35-year-old man who had taken the biologic for 3 years as treatment for ankylosing spondylitis, according to a case report presented in the... »
Arthritis Pattern in Psoriasis Provides Diagnostic Clues
WAIKOLOA, HAWAII – Joint pain arising in a patient with psoriasis is by no means necessarily due to psoriatic arthritis. Psoriasis patients can get osteoarthritis or rheumatoid arthritis, just like individuals without the... »
Quick-Access Clinic Improves Rheumatology Care
An immediate access clinic significantly reduced the wait times for patients seeking rheumatology assessments, based on data from 660 patients seen between February and December 2009. The findings were published in the March... »
CHICAGO – Rheumatoid arthritis more than doubles the risk of fracture in women younger than age 50, according to the results of a large population-based study. While it’s well known that the disease drives up fracture risk... »
Cancer Risk From Biologics in RA Shown Negligible
CHICAGO – Patients with rheumatoid arthritis on antitumor necrosis factor drugs have no greater risk of developing solid cancers than RA patients on disease-modifying antirheumatic drugs, according to an analysis of registry... »
NIAMS Celebrates 25 Years of Advances in Medical Research
BETHESDA, MD. – It’s been 25 years since the establishment of the National Institute of Arthritis and Musculoskeletal and Skin Diseases, and great strides have been made in diagnosis, treatment, and management of numerous... »
| Feb 28 - Mar 4 Sarasota, FL | American Medical Seminars: Rheumatology |
| Mar 21 New York, NY | New York University (NYU): Pediatric Rheumatology |
| Mar 22 - 24 New York, NY | New York University/Hospital for Joint Disease: Seminar in Advanced Rheumatology |
| Mar 28 - 31 Victoria, | Canadian Rheumatology Association (CRA): Scientific Conference and Annual General Meeting |
| Apr 26 - 29 Barcelona, | OsteoArthritis Research Society International (OARSI): World Congress on Osteoarthritis |
| Apr 27 - 29 Chicago, IL | American College of Rheumatology (ACR): State-of-the-Art Clinical Symposium |
| Apr 27 - 28 Baltimore, MD | Johns Hopkins University (JHU): Advances in the Diagnosis and Treatment of the Rheumatic Diseases |
| Apr 27 - 29 Marina del Rey, CA | University of California, Los Angeles (UCLA): Carl M. Pearson Memorial Symposium: Frontiers of Rheumatology |
| May 1 - 4 Glasgow, | British Society for Rheumatology (BSR): Annual Conference (Rheumatology 2012) |
| May 2 - 6 Destin, FL | Congress of Clinical Rheumatology |